CDMO - News

The PCI team never stops innovating. Stay informed about our latest achievements.

Generic API Margins Being Squeezed?

Tags: API Manufacturing | CDMO | GDUFA | Generic Drug Manufacturing

Posted January 14, 2019
Addressing Quality From All Angles in API Manufacturing

Tags: API Manufacturing | Blog | CDMO | cGMP | Quality Systems

Posted January 8, 2019
Generic Drug Makers Continue to Face Hurdles in Race to Make Drugs More Affordable

Tags: API Manufacturing | Blog | CDMO | Generic Drug Manufacturing

Posted December 31, 2018
Why PCI Synthesis is Changing Its Name

Tags: Blog | CDMO | SEQENS | Uncategorized

Posted December 19, 2018
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2019

Tags: API Manufacturing | CDMO | cGMP | FDA | GDUFA | Press Releases

Posted December 11, 2018
Easing Process Validation Rules for Small-Volume Manufacturers Might Be First Step in Easing Drug Shortages

Tags: API Manufacturing | Blog | CDMO | DMFs | Drug Shortage | FDA

Posted December 3, 2018
Generic Drug Makers Continue to Face Hurdles in Race to Make Drugs More Affordable

Tags: API Manufacturing | Blog | CDMO | Generic Drug Manufacturing

Posted November 26, 2018
Easing Process Validation Rules for Small-Volume Manufacturers

Tags: API Manufacturing | Blog | CDMO | DMFs | FDA

Posted November 19, 2018
With New Chemical Entities the Only Constant is Change

Tags: API Manufacturing | Blog | CDMO | cGMP

Posted November 12, 2018
Tighter Restrictions for Drug Approval Around the World Requires a Collaborative Approach

Tags: Blog | CDMO | EMA | FDA

Posted October 29, 2018